Maternal adropin levels in patients with gestational diabetes mellitus: a systematic review and meta-analysis.
Kumar VivekE Prabhakar ReddyBalachandar ThangappazhamHemanth RajFaustino Ramón Pérez-LópezSheshadri Reddy VarikasuvuPublished in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2021)
The results indicate that maternal serum/plasma adropin concentrations were significantly higher in GDM patients as compared to non-GDM controls suggesting the potential associations of adropin in GDM. Despite this, further studies are needed to investigate the mechanistic, diagnostic and prognostic roles of trimester-wise adropin levels in GDM and associated fetal outcomes.
Keyphrases
- pregnancy outcomes
- end stage renal disease
- ejection fraction
- chronic kidney disease
- pregnant women
- newly diagnosed
- birth weight
- peritoneal dialysis
- type diabetes
- gestational age
- patient reported outcomes
- insulin resistance
- skeletal muscle
- metabolic syndrome
- case control
- climate change
- body mass index
- glycemic control